ID: ALA5281072

Max Phase: Preclinical

Molecular Formula: C16H11BrO3

Molecular Weight: 331.17

Associated Items:

Representations

Canonical SMILES:  O=C(/C=C/c1cccc2c1OCO2)c1cccc(Br)c1

Standard InChI:  InChI=1S/C16H11BrO3/c17-13-5-1-4-12(9-13)14(18)8-7-11-3-2-6-15-16(11)20-10-19-15/h1-9H,10H2/b8-7+

Standard InChI Key:  ILOCWNYSKAXEPW-BQYQJAHWSA-N

Associated Targets(Human)

Monoamine oxidase B 8835 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 331.17Molecular Weight (Monoisotopic): 329.9892AlogP: 4.07#Rotatable Bonds: 3
Polar Surface Area: 35.53Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.28CX LogD: 4.28
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.63Np Likeness Score: -0.30

References

1. Guglielmi P, Mathew B, Secci D, Carradori S..  (2020)  Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors.,  205  [PMID:32920430] [10.1016/j.ejmech.2020.112650]

Source